In India, a coalition of groups are calling on Johnson & Johnson to stop exporting Indian-made vaccines to wealthy nations like the United States at a time when hundreds of millions of people remain unvaccinated in India, as well as in Africa. The groups are also urging President Biden to force Johnson & Johnson to license its vaccine to drug manufacturers in India and other nations to help produce more vaccines.
A group of us from civil society, over a dozen organizations in India, drafted a letter very recently to Johnson & Johnson and the Biden administration with a very simple demand, which is that the 600 million doses that Johnson & Johnson is manufacturing currently at a company called Biological E in India should go where the vaccines are most needed, which is the Indian subcontinent, the African continent and the COVAX Facility, rather than where Johnson & Johnson most wants to send them to, which, on the basis of recent history and the company’s experience in South Africa, is Europe and the United States, where it has large, unfulfilled orders, which are quite lucrative, which it seems, in an unseemly manner, eager to supply.
there is a curious difference in the way that Johnson & Johnson is licensing its vaccine around the world. What they’re doing is to provide what’s called
— source democracynow.org | Sep 20, 2021